Calcium receptor modulating compound and use thereof

Details for Australian Patent Application No. 2003265585 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Gyorkos, Albert Charles; Kawase, Masahiro; Corrette, Christopher Peter; Yasuma, Tsuneo; Yoshida, Masato; Pratt, Scott Alan; Kimura, Hiroyuki; Mori, Akira

Agent Griffith Hack

Pub. Number AU-B-2003265585

PCT Number PCT/US03/26317

PCT Pub. Number WO2004/017908

Priority 60/406,012 26.08.02 US; 60/466,129 28.04.03 US

Filing date 21 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 3 July 2008

International Classifications

A61K 31/00 (2006.01)

A61P 19/08 (2006.01) Drugs for skeletal disorders

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

18 December 2003 Complete Application Filed

  Priority application(s): 60/406,012 26.08.02 US; 60/466,129 28.04.03 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003265585

3 July 2008 Application Accepted

  Published as AU-B-2003265585

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003265586-METHOD AND APPARATUS OF CARBON NANOTUBE FABRICATION

2003265584-Diffraction grating-based encoded micro-particles for multiplexed experiments